153 related articles for article (PubMed ID: 29253957)
1. Conjugation of paclitaxel to C-6 hexanediamine-modified hyaluronic acid for targeted drug delivery to enhance antitumor efficacy.
Chen Y; Peng F; Song X; Wu J; Yao W; Gao X
Carbohydr Polym; 2018 Feb; 181():150-158. PubMed ID: 29253957
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
[TBL] [Abstract][Full Text] [Related]
3. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
8. Improved anti-tumor activity and safety profile of a paclitaxel-loaded glycyrrhetinic acid-graft-hyaluronic acid conjugate as a synergistically targeted drug delivery system.
Zhang L; Zhou JP; Yao J
Chin J Nat Med; 2015 Dec; 13(12):915-24. PubMed ID: 26721710
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
Sharma R; Yadav V; Jha S; Dighe S; Jain S
Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
[TBL] [Abstract][Full Text] [Related]
10. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine modified hyaluronic acid-paclitaxel conjugate for efficient oral chemotherapy through mucosal bioadhesion ability.
Jin X; Asghar S; Zhang M; Chen Z; Huang L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Dec; 172():655-664. PubMed ID: 30243219
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
Wang L; Jia E
Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
[TBL] [Abstract][Full Text] [Related]
14. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
Yao J; Zhang L; Zhou J; Liu H; Zhang Q
Mol Pharm; 2013 Mar; 10(3):1080-91. PubMed ID: 23320642
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Hyaluronic Acid-Decorated Redox-Responsive Magnetic Complex Micelle for Targeted Drug Delivery with Enhanced Antitumor Efficiency and Anti-Cell-Migration Activity.
Sang M; Zhang Z; Liu F; Hu L; Li L; Chen L; Feng F; Liu W; Qu W
J Biomed Nanotechnol; 2018 Mar; 14(3):477-495. PubMed ID: 29663921
[TBL] [Abstract][Full Text] [Related]
16. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel.
Zhang J; Han J; Zhang X; Jiang J; Xu M; Zhang D; Han J
Carbohydr Polym; 2015 Sep; 129():25-34. PubMed ID: 26050884
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
20. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release.
Chen Z; He N; Chen M; Zhao L; Li X
Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
